9 March 2026 Punjab Khabarnama Bureau : A new study suggests that certain widely used weight-loss medications could also help lower the risk of developing substance use disorders. Researchers found that people taking drugs used to treat Obesity showed fewer cases of addiction-related conditions compared with those not using these medications.
The research focused on drugs belonging to a class known as GLP‑1 receptor agonists, which are commonly prescribed for weight management and diabetes. Popular medications in this category include Semaglutide and Tirzepatide, which help control appetite and regulate blood sugar levels.
Scientists believe these medications may influence the brain’s reward system, which plays a key role in both eating behavior and addiction. By affecting signals related to cravings and impulse control, the drugs might reduce the likelihood of substance misuse.
The study found a noticeable decline in diagnoses linked to Substance Use Disorder among individuals using these medications. This includes conditions related to alcohol, opioids, and other addictive substances.
Researchers say the findings could open new avenues for understanding how treatments designed for metabolic conditions may also influence mental health and addictive behaviors. However, they emphasized that the medications are not currently approved specifically for treating addiction.
Experts caution that more clinical trials are needed to confirm the connection and determine how these drugs affect the brain’s reward pathways. The study also highlights the importance of carefully evaluating potential side effects and long-term outcomes.
Despite the promising results, medical professionals stress that patients should only use these medications under proper medical supervision and for approved medical purposes.
If further research confirms the findings, these drugs could eventually play a role in addressing both metabolic health and addiction-related disorders.
Summary :
A new study suggests popular weight-loss drugs like semaglutide may lower the risk of substance use disorders by affecting the brain’s reward system, though experts say more research is needed.